{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:42:22Z","timestamp":1778604142061,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"FEDER, The Spanish Ministry of Economy and Competitiveness","award":["MINECO; SAF2014-58653-R"],"award-info":[{"award-number":["MINECO; SAF2014-58653-R"]}]},{"name":"BBVA Foundation and the Michael J. Fox Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.toxrep.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T16:31:51Z","timestamp":1490977911000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Bel\u00e9n","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hilfiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"July (5)","key":"10.1016\/j.toxrep.2017.03.005_bib0005","first-page":"34","article-title":"A delicate balance: iron metabolism and diseases of the brain","volume":"18","author":"Hare","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0015","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","article-title":"Iron metabolism in Parkinsonian syndromes","volume":"21","author":"Berg","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","author":"Hallgren","year":"1958","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinso\u0144s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0035","series-title":"Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders","first-page":"159","article-title":"Parkinso\u0144s disease","author":"Jellinger","year":"2003"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop","volume":"47","author":"Mc Keith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"Dementia with lewy bodies","volume":"3","author":"Mc Keith","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0050","first-page":"475","article-title":"Temporal sequence of Alzheime\u0155s disease-related pathology","volume":"vol. 14","author":"Braak","year":"1999"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0055","doi-asserted-by":"crossref","first-page":"36669","DOI":"10.1038\/srep36669","article-title":"Meta-analysis of brain iron levels of Parkinso\u0144s disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroimage.2012.12.040","article-title":"Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis","volume":"70","author":"Dougherty","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mds.26417","article-title":"Quantitative susceptibility mapping of the midbrain in Parkinso\u0144s disease","volume":"31","author":"Du","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00702-012-0894-8","article-title":"The history of the research of iron in parkinsonian substantia nigra","volume":"119","author":"Friedman","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0075","first-page":"275","article-title":"MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease","volume":"14","author":"Chen","year":"1993","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-196801000-00001","article-title":"Studies on Parkinso\u0144s disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue","volume":"27","author":"Earle","year":"1968","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.870110104","article-title":"Iron in parkinsonian and control substantia nigra-Mossbauer spectroscopy study","volume":"11","author":"Galazka-Friedman","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0090","first-page":"61","article-title":"Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinso\u0144s disease and Alzheime\u0155s disease","volume":"4","author":"Griffiths","year":"1993","journal-title":"Dementia"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0095","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1471-4159.1995.65020710.x","article-title":"Transferrin and iron in normal, Alzheime\u0155s disease, and Parkinso\u0144s disease brain regions","volume":"65","author":"Loeffler","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.410360612","article-title":"Complex I, iron, and ferritin in Parkinso\u0144s disease substantia nigra","volume":"36","author":"Mann","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (111) and total iron content in post mortem substantia nigra of parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JPD-130197","article-title":"Iron deficiency in Parkinsonism: region-specific iron dysregulation in Parkinso\u0144s disease and multiple system atrophy","volume":"3","author":"Visanji","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","article-title":"Iron and reactive oxygen species activity in parkinsonian substantia nigra","volume":"16","author":"Wypijewska","year":"2010","journal-title":"Park. Reat. Disord."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.0b013e31827f0ebb","article-title":"Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease","volume":"80","author":"Yu","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuro.2010.11.006","article-title":"Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells","volume":"32","author":"Salvador","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0140","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s007020100015","article-title":"Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK\/ERK), stress-activated protein kinase\/c-Jun N-terminal kinase (SAPK\/JNK), and p38 kinase expression in Parkinso\u0144s disease and Dementia with Lewy bodies","volume":"108","author":"Ferrer","year":"2001","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0145","first-page":"809","article-title":"Combined kinase inhibition modulates parkin inactivation","volume":"18","author":"Rubio de la Torre","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mrm.21118","article-title":"Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheime\u0155s disease patients","volume":"57","author":"House","year":"2007","journal-title":"Magn. Reson. Med."},{"issue":"7","key":"10.1016\/j.toxrep.2017.03.005_bib0155","first-page":"57","article-title":"Parkinso\u0144s disease-implicated kinases in the brain; insights into disease pathogenesis","volume":"24","author":"Dzamko","year":"2014","journal-title":"Front. Mol. Neurosci. Jun"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0160","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0002-9440(10)64487-2","article-title":"Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases","volume":"161","author":"Zhu","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0165","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","article-title":"Akt as a victim, villain and potential hero in Parkinso\u0144s diseasse pathophysiology and treatment","volume":"31","author":"Greene","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0170","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","article-title":"RTP801 is induced in Parkinso\u0144s disease and mediates neuron death by inhibiting Akt phosphorylation\/activation","volume":"28","author":"Malagelada","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinso\u0144s disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0180","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinso\u0144s disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2011.05.040","article-title":"The role of oxidative stress in neuromelanin synthesis in PC12 cells","volume":"189","author":"He","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxrep.2017.03.005_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-9-27","article-title":"Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinso\u0144s disease","volume":"9","author":"Ayton","year":"2014","journal-title":"Mol. Neurodeg."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0200","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occuring in brain in Parkinso\u0144s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S0317167100029140","article-title":"Regional metal concentrations in Parkinso\u0144s disease, other chronic neurological diseases, and control brains","volume":"16","author":"Uitti","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheime\u0155s disease and Parkinso\u0144s disease: targets for therapeutics","volume":"139","author":"Belaidi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archneurol.2008.586","article-title":"Iron accumulation in the substantia nigra of patients with Alzheimer disease and Parkinsonism","volume":"66","author":"Brar","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.toxrep.2017.03.005_bib0220","article-title":"Regionally progressive accumulation of iron in Parkinso\u0144s disease as measured by quantitative susceptibility mapping","author":"Guan","year":"2016","journal-title":"NMR Biomed."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221475001730015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221475001730015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T19:37:07Z","timestamp":1601840227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221475001730015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":44,"alternative-id":["S221475001730015X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2017.03.005","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}